John Mascarenhas
0000-0002-8400-0483
24 papers found
Refreshing results…
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis
Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53
Ruxolitinib Therapy Followed by Reduced Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis – Myeloproliferative Disorders Research Consortium 114 study
MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis
Missing publications? Search for publications with a matching author name.